Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert
about
HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine developmentBiologic studies of chimeras of highly and moderately virulent molecular clones of simian immunodeficiency virus SIVsmPBj suggest a critical role for envelope in acute AIDS virus pathogenesis.Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell CultureDifferentiating founder and chronic HIV envelope sequences.Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein.Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.
P2860
Q30355260-576838D3-D49E-4179-991E-9FDDA2CA1668Q33843723-16F639DD-14A7-4F63-BDCC-2C9D25D9768DQ33984371-765DB8BE-6528-4145-B730-60289F659F4EQ34309493-84EE60FC-9AB9-4D46-91CA-C95B3F293151Q34342429-29A65CBB-FE0A-42A2-8B7D-36DA51B5A833Q34998032-61021818-E0A2-48B6-AF36-2D363DCE72DAQ35132239-29BBF3BE-116F-4D3E-AB6E-B7D77AF8F5C3Q36097829-0833B3BD-A4AB-407F-9646-6FA9F7AB330DQ36222292-DAD94DE4-3113-4A0C-B568-EC8AA4E600C4Q36277153-544FD94E-6DB7-4072-96FE-4DF69F33E415Q36760049-9C6EE2A1-A889-439A-9B53-EDE8465CE470Q39581340-F7E10D31-2F65-4F1E-9F40-4AA2A1A86E92Q39877884-7322C215-0FA0-4537-A59F-D078CC82EF01
P2860
Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Single amino acid substitution ...... able regions 1 and 2 to revert
@ast
Single amino acid substitution ...... able regions 1 and 2 to revert
@en
type
label
Single amino acid substitution ...... able regions 1 and 2 to revert
@ast
Single amino acid substitution ...... able regions 1 and 2 to revert
@en
prefLabel
Single amino acid substitution ...... able regions 1 and 2 to revert
@ast
Single amino acid substitution ...... able regions 1 and 2 to revert
@en
P2093
P2860
P1433
P1476
Single amino acid substitution ...... able regions 1 and 2 to revert
@en
P2093
P2860
P304
P407
P577
1996-01-01T00:00:00Z